ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "L04AE" (14)Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
Fingolimod (L04AE01) 10 products WHO-DDD  
L IPCI Fingolimod Devatis 0.5 mg28380.52430.2510 %Capsules: FingolimodumDevatis AGB / SL / SGG
L IPCI Fingolimod Devatis 0.5 mg981331.831464.8510 %Capsules: FingolimodumDevatis AGB / SL / SGG
L IPCICMFingolimod Sandoz 0.5 mg28380.52430.2510 %Capsules: FingolimodumSandoz
Pharmaceuticals AG
B / SL / SGG
L IPCICMFingolimod Sandoz 0.5 mg981331.831464.8510 %Capsules: FingolimodumSandoz
Pharmaceuticals AG
B / SL / SGG
  IPCI Fingolimod Devatis 0.25 mg7k.A.Capsules: FingolimodumDevatis AGBG
  IPCI Fingolimod Devatis 0.25 mg28k.A.Capsules: FingolimodumDevatis AGBG
  IPCI Fingolimod Devatis 0.5 mg7k.A.Capsules: FingolimodumDevatis AGBG
  IPCI Fingolimod Devatis 0.5 mg84k.A.Capsules: FingolimodumDevatis AGBG
  IPCICMFingolimod Sandoz 0.25 mg7k.A.Capsules: FingolimodumSandoz
Pharmaceuticals AG
BG
  IPCICMFingolimod Sandoz 0.25 mg28k.A.Capsules: FingolimodumSandoz
Pharmaceuticals AG
BG
Siponimod (L04AE03) 4 products WHO-DDD  
L IPCI Mayzent 0.25 mg12223.83259.8510 %Coated tablets: SiponimodumNovartis Pharma
Schweiz AG
B / SLG
L IPCI Mayzent 0.25 mg1201342.971477.0010 %Coated tablets: SiponimodumNovartis Pharma
Schweiz AG
B / SLG
L IPCI Mayzent 1.00 mg281253.441379.6010 %Coated tablets: Siponimodum 1 mgNovartis Pharma
Schweiz AG
B / SLG
L IPCI Mayzent 2.00 mg281253.441379.6010 %Coated tablets: Siponimodum 2 mgNovartis Pharma
Schweiz AG
B / SLG
 show caption
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home